Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour

Journal of Intellectual Disability Research

Volumn 59, Issue 1, 2015, Pages 11-25

  Deb, S ^a   Unwin, G ^b   Deb, T ^c  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adults; Aggressive behaviour; Antipsychotics; Intellectual disabilities; Psychotropics

Indexed keywords

AMITRIPTYLINE; ATOMOXETINE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLOBAZAM; CLOMIPRAMINE; DIAZEPAM; DOSULEPIN; ETIRACETAM; FLUOXETINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LORAZEPAM; MELATONIN; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; TOPIRAMATE; TRAZODONE; VALPROIC ACID; ZONISAMIDE; ZOPICLONE; ZUCLOPENTHIXOL;

ADULT; AGE; AGGRESSION; ARTICLE; DEMOGRAPHY; EPILEPSY; FOLLOW UP; GENDER; HEALTH; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; POLYPHARMACY; PSYCHIATRIC DIAGNOSIS; FEMALE; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGY;

ADULT; AGGRESSION; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; POLYPHARMACY; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS;

EID: 84918770870     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/jir.12119     Document Type: Article

References (46)

1. Ahmed Z., Fraser W., Kerr M. P., Kiernan C., Emerson E., Robertson J. etal. (2000) Reducing antipsychotic medication in people with a learning disability. The British Journal of Psychiatry 176, 42-46.
2. Aman G., Alvarez N., Benefield W., Crismon M., Green G., King B. etal. (Editorial Board) (2000) Treatment of psychiatric and behavioural problems in mental retardation. American Journal on Mental Retardation 105, 159-228.
3. Aman M. G., Burrow W. H. & Wolford P. L. (1995a) The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes. American Journal of Mental Retardation 100, 283-292.
4. Aman M. G., Sarpharc G. & Burrow W. H. (1995b) Psychotropic drugs in group homes: prevalence and relation to demographic and psychiatric variables. American Journal on Mental Retardation 99, 500-509.
5. Berney T. & Deb S. (2012) Epilepsy in learning disability. In: Oxford Textbook of Epilepsy and Epileptic Seizures: Oxford Textbooks in Clinical Neurology (eds S. Shorvon, R. Guerrini, M. Cook & S. Lahtoo ), pp. 195-199. Oxford University Press, Oxford.
6. Bhaumik S. & Branford D. (eds) (2008) The Frith Prescribing Guidelines: For Adults with Intellectual Disability. HealthComm. UK Ltd, Aberdeen.
7. Branford D. (1996a) A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire. Journal of Intellectual Disability Research 40, 358-368.
8. Branford D. (1996b) Factors associated with successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities. Journal of Intellectual Disability Research 40, 322-329.
9. Burd L., Williams M., Klug M. G., Fjelstad K., Schimke A. & Kerbeshian J. (1997) Prevalence of psychotropic and anticonvulsant drug use among North Dakota group home residents. Journal of Intellectual Disability Research 41, 488-494.
10. Crocker A. G., Mercier C., Lachapelle Y., Brunet A., Morin D. & Roy M.-E. (2006) Prevalence and types of aggressive behaviour among adults with intellectual disabilities. Journal of Intellectual Disability Research 50, 652-661.
11. Deb S. (2013) Pharmacotherapy. In: Handbook of Psychopathology in Intellectual Disability: Research, Practice, and Policy, Autism and Child Psychopathology Series (eds E. Tsakanikos & J. McCarthy ), Chapter 19, pp. 307-324. Springer Science + Business Media, New York .
12. Deb S. & Fraser W. I. (1994) The use of psychotropic medication in people with learning disability: towards rational prescribing. Human Psychopharmacology 9, 259-272.
13. Deb S. & Gomez A. (2010) A case series on the use of risperidone for the management of aggression in adults with intellectual disabilities. Advances in Mental Health and Intellectual Disabilities 4, 39-44.
14. Deb S., Matthews T., Holt G. & Bouras N. (eds) (2001) Practice Guidelines for the Assessment and Diagnosis of Mental Health Problems in Adults with Intellectual Disability. European Association for Mental Health in Mental Retardation (EAMHMR), Pavilion Press, London. Available at: http://www.slam.nhs.uk (retrieved 10 January 2014).
15. Deb S., Sohanpal S. K., Soni R., Unwin G. & Lenôtre L. (2007) The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities. Journal of Intellectual Disability Research 51, 766-777.
16. Deb S., Chaplin R., Sohanpal S., Unwin G., Soni R. & Lenôtre L. (2008) The effectiveness of mood stabilisers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review. Journal of Intellectual Disability Research 52, 107-113.
17. Deb S., Kwok H., Bertelli M., Salvador-Carulla L., Bradley E., Torr J. etal. (2009) International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry 8, 181-186.
18. Doan T. N., Lennox N. G., Taylor-Gomez M. & Ware R. S. (2013) Medication use among Australian adults with intellectual disability in primary health care settings: a cross sectional study. Journal of Intellectual and Developmental Disability 38, 177-181.
19. Donley M., Chan J. & Webber L. (2011) Disability support workers' knowledge and education needs about psychotropic medication. British Journal of Learning Disabilities 40, 286-291. doi: 10.1111/j.1468-3156.2011.00707.x.
20. Edwards N. (2003) The mini PAS-ADD interview pack. Journal of Intellectual Disability Research 47, 493-494.
21. Hemmings C., Deb S., Chaplin E., Hardy S. & Mukherjee R. (2013) Research for people with intellectual disabilities and mental health problems: a view from the UK. Journal of Mental Health Research in Intellectual Disability 6, 127-158.
22. Holden B. & Gitlesen J. P. (2004) Psychotropic medication in adults with mental retardation: prevalence, and prescription practices. Research in Developmental Disabilities 25, 509-521.
23. IBM. (2011) IBM SPSS 20 Statistics Core System Users' Guide. Microsoft, IBM copyright.
24. de Kiujper G., Hoekstra P., Visser F., Scholte F. A., Penning C. & Evenhuis H. (2010) Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription. Journal of Intellectual Disability Research 54, 659-667.
25. de Kuijper G. M. & Hoekstra P. (2010) Antipsychotics in patients with ID: a controlled discontinuation study. Journal of Applied Research in Intellectual Disabilities Supplement, 423.
26. Lunsky Y., Emery C. F. & Benson B. A. (2002) Staff and self-reports of health behaviours, somatic complaints, and medications among adults with mild intellectual disability. Journal of Intellectual and Developmental Disability 27, 125-135.
27. Moss S. (2002) The Mini PAS-ADD Interview Pack. Pavilion Publishing, London.
28. Nøttestad J. A. & Linaker O. M. (2003) Psychotropic drug use among people with intellectual disability before and after deinstitutionalisation. Journal of Intellectual Disability Research 47, 464-471.
29. Oliver P. C., Crawford M. J., Rao B., Reece B. & Tyrer P. (2007) Modified overt aggression scale (MOAS) for people with intellectual disability and aggressive challenging behaviour: a reliability study. Journal of Applied Research in Intellectual Disabilities 20, 368-372.
30. Prosser H., Moss S., Costello H., Simpson N., Patel P. & Rowe S. (1998) Reliability and validity of the Mini PAS-ADD for assessing psychiatric disorders in adults with intellectual disability. Journal of Intellectual Disability Research 42, 264-272.
31. Ratey J. J. & Gutheil C. M. (1991) The measurement of aggressive behaviour: reflections on the use of the Overt Aggression Scale and the Modified Overt Aggression Scale. Journal of Neuropsychiatry 3, 557-560.
32. Reiss S. & Aman M. G. (1998) Psychotropic Medication and Development Disabilities: The International Consensus Handbook. Ohio State University, Columbus, OH.
33. Silver J. M. & Yudofsky S. C. (1991) The Overt Aggression Scale: overview and guiding principles. Journal of Neuropsychiatry 3, 522-529.
34. Singh N. N., Ellis C. R., Donatelli L. S., Williams D. E., Ricketts R. W., Goza A. B. etal. (1996) Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation. Journal of Intellectual Disability Research 40, 1-7.
35. Sohanpal S. K., Deb S., Thomas C., Soni R., Lenôtre L. & Unwin G. (2007) The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review. Journal of Intellectual Disability Research 51, 750-765.
36. Stolker J. J., Koedoot P. J., Heerdink E. R., Leufkens H. G. & Nolen W. A. (2002) Psychotropic drug use in intellectually disabled group-home residents with behavioural problems. Pharmacopsychiatry 35, 19-23.
37. Taylor D. (2010) Antipsychotic polypharmacy-confusion reigns. The Psychiatrist 34, 41-43.
38. The AGREE Collaboration. (2001) Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. Available at: http://www.agreetrust.org (retrieved 10 January 2014).
39. Tyrer P., Oliver-Africano P. C., Ahmed Z., Bouras N., Cooray S., Deb S. etal. (2008) Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trail. Lancet 371, 57-63.
40. Unwin G. & Deb S. (2008a) Use of medication for the management of behaviour problems among adults with intellectual disabilities: a clinicians' consensus survey. American Journal on Mental Retardation 113, 19-31.
41. Unwin G. & Deb S. (2008b) Psychiatric and behavioural assessment scales for adults with learning disabilities. Advances in Mental Health and Learning Disability 2, 37-45.
42. Unwin G. & Deb S. (2009) The effectiveness of interventions on aggression in adults with intellectual disabilities: a naturalistic observational study. World Psychiatry 8 (S1), 237.
43. Unwin G. & Deb S. (2011b) Family caregiver uplift and burden: Associations with aggressive behaviour in adults with intellectual disability. Journal of Mental Health Research in Intellectual Disability 4, 186-205.
44. Unwin G. L. & Deb S. (2010) The use of medication to manage problem behaviours in adults with a learning disability: a national guideline. Advances in Mental Health and Intellectual Disabilities 4, 4-11.
45. Unwin G. L. & Deb S. (2011a) Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: a systematic review. Research in Developmental Disabilities 32, 2121-2133.
46. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva.